Aker BioMarine's science-first approach continues to drive innovation in nutrition research, advancing clinically substantiated wellness solutions through leading academic partnerships.
Aker BioMarine has been named a finalist in the Nutrition Research Project category of the 2026 NutraIngredients USA Awards for its role in the study, Benefits of Krill Oil Supplementation During Alternate-Day Fasting in Adults with Overweight and Obesity.
Widely recognized as one of the nutrition industry’s most prestigious award programs, the NutraIngredients USA Awards celebrate excellence in ingredients, health initiatives, and nutritional science. Being selected as a finalist further reinforces Aker BioMarine’s leadership and longstanding commitment to advancing evidence-based nutrition research.
“The most impactful scientific advances happen through strong partnerships and collaborations with academic institutions and research groups that bring deep, specialized expertise,” said Line Johnsen, SVP of Human Health Ingredients R&D at Aker BioMarine. “For years, Aker BioMarine has been committed to investing in clinical studies and nutrition science to better understand the health benefits of krill-based ingredients. This commitment to rigorous research is increasingly important in the supplement industry, where clinical substantiation and measurable health outcomes are essential.”
The Study and Scientific Leadership
The finalist recognition highlights a study led by Dr. Stuart Gray, Professor at the University of Glasgow’s School of Cardiovascular & Metabolic Health, Dentistry and Nursing. A leading expert in human muscle physiology, aging, exercise, nutrition, and metabolic health, Dr. Gray brought extensive scientific expertise to the project. The study has undergone rigorous scientific evaluation, strengthening confidence in its findings among researchers, healthcare professionals, industry stakeholders, and consumers alike.
The research examined the impact of Superba Boost Krill oil supplementation during alternate-day fasting in adults with overweight and obesity. Results suggest that Superba Boost may help improve the quality of weight loss by supporting the preservation of muscle mass and functional strength while promoting fat loss. These findings position krill oil as a science-backed nutritional strategy for individuals seeking healthier and more sustainable weight management outcomes.
Relevance in the GLP-1 Era
The study arrives at a particularly relevant moment for the health and wellness industry. As GLP-1–based therapies continue to transform weight management through appetite suppression and improved glycemic control, concerns are growing about unintended muscle loss during rapid weight reduction. Preserving lean muscle mass has become an increasingly important focus for clinicians, researchers, and consumers alike. The findings from this study suggest that krill oil may serve as a valuable complementary nutritional intervention for individuals pursuing weight loss, including those using GLP-1 therapies.
Beyond its immediate clinical relevance, the research carries broader implications for public health. Maintaining muscle mass and strength during weight loss remains a significant challenge for millions of adults, particularly as rapid weight-loss interventions become more widespread. Muscle loss is associated with reduced metabolic health, increased frailty, diminished mobility, and a lower quality of life. By highlighting the potential role of krill oil supplementation in mitigating these risks, the study contributes to a growing body of evidence supporting nutritional strategies that promote functional strength, metabolic resilience, and healthy aging.
Aker BioMarine has long recognized muscle health as a strategic area of focus, and this latest research further underscores its importance within modern weight management approaches. The study reinforces the potential of krill oil supplementation as a valuable tool for helping individuals preserve muscle during weight loss while supporting overall health and wellness outcomes.
Looking Ahead to the 2026 NutraIngredients USA Awards
“By collaborating with leading institutions such as the University of Glasgow’s School of Cardiovascular & Metabolic Health, Dentistry and Nursing, we can translate scientific research into meaningful, real-world studies, and programs like the NutraIngredients Awards recognize this work, and we are proud to be recognized among industry leaders in this area,” added Johnsen.
Winners of the 2026 NutraIngredients USA Awards will be announced this July in Chicago, where many of the industry’s leading researchers, ingredient innovators, and health companies will gather to celebrate advancements shaping the future of nutrition.
%20Weight.webp?width=2917&height=1250&name=Blog_Article_Illustrations_1(1)%20Weight.webp)